Mulligan Seamus (CIK 1536639) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy JAZZ (1,605 shares), Buy JAZZ (3,415 shares), Buy JAZZ (3,507 shares), Buy JAZZ (80,684 shares), Buy JAZZ (19,216 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,605 | $0 |
| 2026-06-01 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,415 | $471,543 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-05-13 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 80,684 | $7.9M |
| 2025-05-13 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 19,216 | $1.9M |
| 2025-05-13 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 100 | $9,971 |
| 2025-05-13 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 1,621 | $166,963 |
Source: SEC Form 4 filings · as of 2026-08-07